Cybersecurity & Trade Controls: China’s cyberspace regulator has launched a cybersecurity review of Palo Alto Networks products sold in China, citing risks to critical infrastructure and national security, as Beijing tightens scrutiny of foreign tech amid US-China tech tensions. Cross-border Crime Update: Hong Kong police say losses from the “Fun Coffee” crypto scam may be higher than first feared, with Macau authorities reporting additional claims and arrests across both cities. AI-Driven Oncology Deal: Alphamab Oncology licensed overseas rights to its experimental cancer drug JSKN016 to Pathos AI in a deal potentially worth over US$2.2B, with Pathos covering overseas development outside Greater China. Macao Talent & GBA Integration: Macau’s government is urging residents abroad to return, backed by a new information platform covering jobs, startups, housing, and re-entry procedures to support Greater Bay Area development. Health & Clinical Research: Hong Kong’s health innovation steering committee reviewed progress to strengthen the clinical trial ecosystem and standardise processes via the Greater Bay Area International Clinical Trial Institute. Macao-Hengqin Mobility: Hengqin Port’s Guangdong-Macao one-stop lanes saw cross-border vehicle crossings jump about 40% year-on-year in the first seven months, highlighting growing traffic flows. University Tech Capacity: UM ran a biomedical sciences summer camp for over 70 students, using lab sessions to spark interest in life sciences research and innovation. Fujian-Macao Cooperation: Macau’s Chief Executive met Fujian enterprises in Fuzhou to push trade, innovation, and Hengqin opportunities, as both sides signed cooperation agreements across multiple sectors.